At a glance

ClinicalIndex Comparison Record

Phase 4Completed

Drug / intervention

Intravenous Clarithromycindrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00297674

NCT00297674Phase 4Completed

Compare CT.gov

Clarithromycin as Immunomodulatory Therapy for the Management of Septic Syndrome by Ventilator-Associated Pneumonia

University of Athens·interventional·Posted Feb 28, 2006·Updated Feb 28, 2006

In Brief

A Phase 4 clinical trial evaluating Intravenous Clarithromycin for Sepsis and Ventilator Associated Pneumonia. Completed, across 3 sites.

Detailed Summary

The aim of this clinical trial is to clarify the clinical efficacy of clarithromycin as immunotherapy for the management of septic syndrome by ventilator-associated pneumonia.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsSepsis, Ventilator Associated Pneumonia

CountriesGreece

Collaborators--

Timeline

Phase 4CompletedFinished

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartJun 2004

Study CompletionDec 2005

First PostedFeb 2006

TodayJul 2026

First PostedFeb 28, 2006

Enrollment StartJun 1, 2004

Study CompletionDec 1, 2005

TodayJul 2, 2026

Posted 20.3 years ago

Interventions

Intravenous Clarithromycindrug